Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

News

  • Home
  •  
  • News



  • Most Read
  • Latest Comments
  • Magic mushrooms company Tryp prepares for ASX listing via $14.3m backdoor merger with Exopharm
    • News

    RBA and ASIC up the ante on blockchain project, ASX writes off millions
    Public
  • Magic mushrooms company Tryp prepares for ASX listing via $14.3m backdoor merger with Exopharm
    • News

    Smart pain assessment app now used by more than half of Australia’s residential aged care providers
    Public
  • Magic mushrooms company Tryp prepares for ASX listing via $14.3m backdoor merger with Exopharm
    • News

    Fledgling fintech hopes millennials put their Douugh into micro-investing ‘super’ app
    Public
  • Magic mushrooms company Tryp prepares for ASX listing via $14.3m backdoor merger with Exopharm
    • News

    🎵 The knee bone’s connected to the… collagen rope device (?!)
    Public
  • Magic mushrooms company Tryp prepares for ASX listing via $14.3m backdoor merger with Exopharm
    Opening a new frontier in treating Parkinson’s disease
    • Review
    • November 11, 2022
  • Tremors from the FTX collapse continue to be felt as DigitalX sells off 15% Bitcoin holdings
    • Review
    • January 10, 2023
  • AUDC stablecoin gathers momentum as Novatti confirms integration with XRP Ledger
    • Review
    • June 9, 2022
  • PharmAust completes dosing first cohort for MND treatment, patients respond positively
    • Review
    • January 6, 2023
  • Parkinson’s UK backs Pharmaxis with $5 million to slow the onset of incurable disease with ‘ground breaking’ trial
    • Review
    • September 1, 2022

Latest Articles

  • Imagion Biosystems Advances MagSense® Phase 2 Trial
    Imagion Biosystems Advances MagSense® Phase 2 Trial
    • News

  • Acrux-developed Menopause Hormone Therapy to enter Australian market
    Acrux-developed Menopause Hormone Therapy to enter Australian market
    • News

  • Bioxyne leads the way as Australia’s first manufacturer of pharmaceutical cannabis gummies
    Bioxyne leads the way as Australia’s first manufacturer of pharmaceutical cannabis gummies
    • News

  • Tryptamine Therapeutics’ psilocybin trials deliver pain relief to all patients
    Tryptamine Therapeutics' psilocybin trials deliver pain relief to all patients
    • News

  • Actinogen’s Phase 2a clinical trial for depression treatment fails to meet primary endpoint, shares tank
    Actinogen’s Phase 2a clinical trial for depression treatment fails to meet primary endpoint, shares tank
    • News

  • Complii to acquire MIntegrity with plans to expand its client base and cross-sell regtech
    • News

    Complii to acquire MIntegrity with plans to expand its client base and cross-sell regtech

    Financial compliance consulting business Complii (ASX: CF1) is set to acquire financial services company MIntegrity to expand its regtech offerings and client base. This follows Complii’s acquisition of online share registry Registry Direct in August 2022.  As part of the acquisition, the Company has gained control of all of MIntegrity’s assets, including the MIntegrity brand,

    Read More
    Public
  • Integrated payment capabilities for merchants and digital wallets driving Novatti growth
    • News

    Integrated payment capabilities for merchants and digital wallets driving Novatti growth

    Over the past three years, cash payments have halved according to the Reserve Bank’s latest data, a societal trend being capitalised on by fintech company Novatti Group (ASX: NOV) which is benefiting through a 46% increase in their digital payments processing.  Novatti has spent the last few years developing their digital payments ecosystem which allows

    Read More
    Public
  • Call for help: Dubber pushes call recording AI amid growing struggles
    • News

    Call for help: Dubber pushes call recording AI amid growing struggles

    Call recording and voice intelligence software Dubber (ASX: DUB), boasting major clients like Telstra, Microsoft, Cisco and Optus, is pushing its AI tech and knowledge to recover from its intense cash burn in FY23.  Pointing to its wins, the Company mentioned that Dubber’s platform was now a part of Telstra and Optus networks. By the

    Read More
    Public
  • PointsBet stems its losses with first payment from Fanatics for US business
    • News

    PointsBet stems its losses with first payment from Fanatics for US business

    Having widened its losses in FY23, wagering company PointsBet Holdings (ASX: PBH) has decided to let go of its US divisions, selling them to US-based Fanatics Betting and Gaming (FBG) for $333 million.  The Company has received $270.10 million (along with agreed-upon adjustments) as the first payment out of the total purchase amount of $333

    Read More
    Public
  • As allied health services thrive, Healthia receive $260m offer to be acquired at 84% premium
    • News

    As allied health services thrive, Healthia receive $260m offer to be acquired at 84% premium

    It has not taken long for private enquiry firms to circle Healthia (ASX: HLA), Australia fastest growing physiotherapy and podiatry operator which has received an offer to be 100% acquired for $260 million.  The binding Scheme Implementation Deed comes from Harold BidCo, an entity owned by funds advised by Pacific Equity Partners (PEP) at $1.80

    Read More
    Public
  • Invest in good investors, UNITH delivers big jump in value behind tech of its digital humans
    • News

    Invest in good investors, UNITH delivers big jump in value behind tech of its digital humans

    For many investors, backing proven stock pickers can deliver mammoth returns. Just look at the Berkshire Hathaway investors that assign Warren Buffett to invest for them. But when it comes to artificial intelligence, younger heads may be the ones to follow as evidenced by AI company UNITH (ASX: UNT) which develops digital humans and reported

    Read More
    Public
  • After 20% headcount reduction, Airtasker reports revenue growth as business starts turning
    • News

    After 20% headcount reduction, Airtasker reports revenue growth as business starts turning

    Need some extra cash or extra assistance? Sites like online marketplace Airtasker (ASX: ART) make it possible. After suffering a slew of losses in FY22, the Company had to make some drastic moves to get back on track, and it appears to be working. Airtasker Group posted revenue growth of 40.4% on FY22 to $44.2

    Read More
    Public
  • Medical Developments eyes US commercialisation for Penthrox as it scales back in France
    • News

    Medical Developments eyes US commercialisation for Penthrox as it scales back in France

    After scaling back investments in France and pulling the plug on its China trials, Aussie emergency medical solutions company Medical Developments International (ASX: MVP) has a renewed focus, one that helped it reduce its losses from $12.4 million in FY22 to $5.6 million in FY23.  The earnings report showed a net gain of $10.3 million

    Read More
    Public
  • Harris Technology slashes inventory by 52%, encouraging sales from new international business
    • News

    Harris Technology slashes inventory by 52%, encouraging sales from new international business

    While rising interest rates put financial pressure on Australian households which slashed discretionary spending, online retailers could either take the high road or prepare their businesses to bounce back. For online retailer Harris Technology (ASX: HT8), it’s been the case of the latter through prudent cash management and upgrading into new verticals that will drive

    Read More
    Public
  • Careteq further penetrates its large and growing addressable market
    • News

    Careteq further penetrates its large and growing addressable market

    Addressing industry thematics of cloud-based computing and technology disruption and the rapid aging of Western populations, Careteq (ASX:CTQ ) has released FY23 results that  demonstrate it is penetrating these addressable markets and is moving closer to creating a sustainable business.  Its suite of leading cloud-based assistive living technology solutions, encompassing intelligent sensors and devices, materially

    Read More
    Public
  • «
  • ‹
  • 87
  • 88
  • 89
  • 90
  • 91
  • ›
  • »

Login or register for free to access unlimited reading

Register Now!
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.